Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ERB > SEC Filings for ERB > Form 8-K on 27-May-2014All Recent SEC Filings

Show all filings for ERBA DIAGNOSTICS, INC.

Form 8-K for ERBA DIAGNOSTICS, INC.


27-May-2014

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On May 20, 2014, Sanjiv Suri, the Interim Chief Executive Officer of ERBA Diagnostics, Inc. (the "Company"), delivered notice to the Company of his intention to resign effective as of June 1, 2014.

(c) Effective as of June 1, 2014, Mohan Gopalkrishnan will become the Chief Executive Officer of the Company. Mr. Gopalkrishnan, age 58, has served as Vice President - Operations of the Company since October 2012. Prior to joining the Company, Mr. Gopalkrishnan spent 15 years with Becton Dickinson in a number of leadership roles including as Senior Director with global responsibility for the pre-analytical systems business unit, Business Director of the Asia-Pacific region, ERP Leader of the Asia-Pacific region and General Manager of the medical/surgical division. Mr. Gopalkrishnan is expected to be employed by the Company pursuant to an employment agreement to be mutually agreed upon by Mr. Gopalkrishnan and the Company and to be approved by the Compensation Committee and the Board of Directors of the Company, which employment agreement has not been finalized as of the date of this Current Report on Form 8-K.

Effective as of June 1, 2014, Prakash Patel will become the Controller of the Company. Mr. Patel, age 45, has served as Assistant Controller of the Company since June 3, 2013, and as the Principal Financial Officer and Principal Accounting Officer of the Company since June 30, 2013. Prior to his employment with the Company, Mr. Patel was Controller of Perry Baromedical Corporation from 2011 to May 2013, and Corporate Controller of PostiveID Health Care Products from 2007 to 2011. Mr. Patel is expected to be employed by the Company pursuant to an employment agreement to be mutually agreed upon by Mr. Patel and the Company and to be approved by the Compensation Committee and the Board of Directors of the Company, which employment agreement has not been finalized as of the date of this Current Report on Form 8-K.

  Add ERB to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ERB - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.